BAXTER INTERNATIONAL INC BAX
Surgical & Medical Instruments & Apparatus ยท NYSE
์์ต
$10.36B
+3.0% ๋
๋๋
๋
์์์ต
$2.66B
+209.2% ๋
๋๋
๋
์ด ์์ฐ
$25.78B
-8.8% ๋
๋๋
๋
EPS
5.23
+208.3% ๋
๋๋
๋
Advertisement
Income Statement
| ๊ธฐ๊ฐ | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Revenues | $8.27B | $5.43B | $2.62B | $10.36B | $7.88B | $5.18B | $2.49B | $10.06B |
| Gross Profit | $2.80B | $1.85B | $861.00M | $4.15B | $3.02B | $1.99B | $961.00M | $3.55B |
| R&D Expense | $392.00M | $274.00M | $140.00M | $518.00M | $379.00M | $250.00M | $120.00M | $450.00M |
| SG&A Expense | $2.13B | $1.42B | $703.00M | $2.95B | $2.21B | $1.45B | $729.00M | $3.10B |
| Operating Income (Loss) | $421.00M | $249.00M | $58.00M | $707.00M | $449.00M | $294.00M | $115.00M | $-2.85B |
| Interest Expense | โ | โ | โ | $508.00M | โ | โ | โ | $413.00M |
| Net Income (Loss) | $171.00M | $217.00M | $126.00M | $2.66B | $-137.00M | $-277.00M | $37.00M | $-2.43B |
| EPS (Diluted) | 0.33 | 0.42 | 0.25 | 5.23 | -0.27 | -0.54 | 0.07 | -4.83 |
์ฌ๋ฌดํ
| ๊ธฐ๊ฐ | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.05B | $20.05B | $20.05B | $25.78B | $25.78B | $25.78B | $25.78B | $28.28B |
| Current Assets | $6.87B | $6.87B | $6.87B | $8.85B | $8.85B | $8.85B | $8.85B | $9.60B |
| Cash & Equivalents | $1.73B | $1.69B | $2.29B | $3.08B | $1.42B | $1.57B | $2.83B | $1.62B |
| Accounts Receivable | $1.86B | $1.86B | $1.86B | $1.68B | $1.68B | $1.68B | $1.68B | $1.72B |
| Inventory | $2.23B | $2.23B | $2.23B | $2.05B | $2.05B | $2.05B | $2.05B | $1.92B |
| PP&E (Net) | $2.91B | $2.91B | $2.91B | $2.87B | $2.87B | $2.87B | $2.87B | $2.87B |
| Goodwill | $4.93B | $4.93B | $4.93B | $5.28B | $5.28B | $5.28B | $5.28B | $5.79B |
| Total Liabilities | $13.95B | $13.95B | $13.95B | $18.76B | $18.76B | $18.76B | $18.76B | $19.81B |
| Current Liabilities | $2.97B | $2.97B | $2.97B | $6.51B | $6.51B | $6.51B | $6.51B | $6.50B |
| Accounts Payable | $999.00M | $999.00M | $999.00M | $968.00M | $968.00M | $968.00M | $968.00M | $881.00M |
| Long-Term Debt | โ | โ | โ | $9.44B | โ | โ | โ | $13.18B |
| Stockholders Equity | $6.13B | $6.13B | $6.13B | $6.96B | $6.96B | $6.96B | $6.96B | $8.40B |
Cash Flow Statement
| ๊ธฐ๊ฐ | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $261.00M | $24.00M | $-193.00M | $1.73B | $531.00M | $278.00M | $163.00M | $1.21B |
| Investing Cash Flow | $3.04B | $3.15B | $3.27B | $3.21B | $-421.00M | $-257.00M | $-166.00M | $-931.00M |
| Financing Cash Flow | $-4.07B | $-3.99B | $-3.23B | $-3.49B | $-1.22B | $-1.08B | $-140.00M | $-1.44B |
| Stock Repurchases | โ | โ | โ | โ | โ | โ | โ | $32.00M |
์ ์ฌ ๊ธฐ์
BECTON DICKINSON & CO
BDX
BOSTON SCIENTIFIC CORP
BSX
DEXCOM INC
DXCM
3M CO
MMM
INSULET CORP
PODD
RESMED INC
RMD
Solventum Corp
SOLV
STRYKER CORP
SYK
๋ ์์๋ณด๊ธฐ
How to Find Any SEC Filing in Two MinutesCash-Flow Quality: Profit Is an Opinion, Cash Is a FactValuation Basics: P/E, P/S and What They Actually Tell YouDividends: How Companies Pay Shareholders and How to Read ThemHow to Read a 10-K Annual Report (Without Falling Asleep)Understanding Earnings Per Share (EPS)How to Read a Cash Flow StatementHow to Read a Balance SheetHow to Read an Income Statement
๋ฐ์ดํฐ๋ ๋ฏธ๊ตญ SEC EDGAR ๊ณต๊ณต ๋ฐ์ดํฐ๋ฒ ์ด์ค์์ ์์ง๋์์ต๋๋ค. ์ด ์ฌ์ดํธ๋ ํฌ์ ์กฐ์ธ์ ์ ๊ณตํ์ง ์์ต๋๋ค.